Secernentea Infections Overview

Save information for later
Sign Up

Learn About Secernentea Infections

View Main Condition: Intestinal Parasitosis

What is the definition of Secernentea Infections?
A Secernentea infection is caused by a type of parasitic worm (nematode) that is transmitted to humans by eating contaminated fruits and vegetables, drinking contaminated water, or ingesting soil from unwashed hands. The worms then migrate from the intestinal tract to other parts of the body, such as the lungs.
What are the symptoms of Secernentea Infections?
While some individuals may have no symptoms at all, symptoms of a Secernentea infection include abdominal pain, diarrhea, intestinal ulceration, nausea, vomiting, insomnia, headache, fever, itching, painful or stinging skin bumps, rashes, asthma, chronic skin ulcers, swollen or infected lymph nodes, progressive swelling of limbs or genitalia, cold legs, milky, white urine, muscle pain, joint swelling, organ damage, vision loss, skin hemorrhages, cough, chest pain, difficulty breathing, pneumonia, bowel, bile duct, or pancreatic duct obstruction, appendicitis, malnutrition, and delayed growth and development.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Secernentea Infections?
Treatment for Secernentea infections involves the use of anthelmintic (anti-parasite) drugs, such as mebendazole, pyrantel, levamisole, or albendazole.
Who are the top Secernentea Infections Local Doctors?
Stephen A. Ward
Elite in Secernentea Infections
Stephen A. Ward
Elite in Secernentea Infections
Stephen A. Ward
Pembroke Place, 
Liverpool, ENG, GB 

Stephen Ward practices in Liverpool, United Kingdom. Mr. Ward is rated as an Elite expert by MediFind in the treatment of Secernentea Infections. His top areas of expertise are Lymphatic Filariasis, Spirurida Infections, Onchocerciasis, and Secernentea Infections.

Elite in Secernentea Infections
Joseph Kamgno
Elite in Secernentea Infections
Joseph Kamgno
Yaounde, CE, CM 

Joseph Kamgno practices in Yaounde, Cameroon. Mr. Kamgno is rated as an Elite expert by MediFind in the treatment of Secernentea Infections. His top areas of expertise are Loiasis, Onchocerciasis, Spirurida Infections, and Secernentea Infections.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Secernentea Infections
Louise A. Hope-Kelly
Elite in Secernentea Infections
Louise A. Hope-Kelly
Pembroke Place, 
Liverpool, ENG, GB 

Louise Hope-Kelly practices in Liverpool, United Kingdom. Ms. Hope-Kelly is rated as an Elite expert by MediFind in the treatment of Secernentea Infections. Her top areas of expertise are Lymphatic Filariasis, Spirurida Infections, Secernentea Infections, and Lymphedema.

View All Doctors
What are the latest Secernentea Infections Clinical Trials?
Host Response to Infection and Treatment in the Filarial Diseases of Humans
Host Response to Infection and Treatment in the Filarial Diseases of Humans
Enrollment Status: Recruiting
Publish Date: October 07, 2025
Intervention Type: Drug

Summary: This study will evaluate and treat patients with filarial infections to explore in depth the immunology of the disease, including susceptibility to infection, disease development, and response to treatment. Filarial infections are caused by parasitic worms. The immature worm (larva) is transmitted to a person through a mosquito bite and grows in the human body to 2 to 4 inches in length. Although ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Hookworm (Ancylostoma Duodenale and Necator Americanus), Ascaris Lumbricoides, and Trichuris Trichiura in Pediatric and Adult Participants
A Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Hookworm (Ancylostoma Duodenale and Necator Americanus), Ascaris Lumbricoides, and Trichuris Trichiura in Pediatric and Adult Participants
Enrollment Status: Recruiting
Publish Date: September 25, 2025
Intervention Type: Drug
Study Phase: Phase 3

Summary: This is a Phase 3, multi-center, prospective, randomized, double-blind, placebo-controlled study to evaluate the effectiveness, safety, and tolerability of ZP5-9676 compared to placebo for the treatment of STH infections. Approximately 300 participants will be enrolled, randomized at the Baseline visit (Day 1) to one of the following treatments in a 1:1 ratio of active and placebo.

View All Clinical Trials